Get notified when JAGX files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Delisting (new) — Company faces imminent delisting from Nasdaq if it fails to maintain $1.00 bid price for 10 consecutive days by May 18, 2026.
Jaguar Health granted 3-day extension to avoid Nasdaq delisting, deadline now May 18
Filed May 7, 2026 · Period ending May 6, 2026 · ~1 min read
Key Changes
-
high
Nasdaq granted extension to May 18, 2026 (from May 15) for Jaguar to maintain $1.00 bid price for 10 consecutive days or face delisting from the exchange.
Item 3.01 view on EDGAR → -
high
Company regained compliance with 500,000 publicly held shares requirement on May 4 after warrant exercises, but this reset the clock on bid price compliance.
Item 3.01 view on EDGAR → -
medium
Jaguar had received two separate non-compliance notices from Nasdaq in early May: one for publicly held shares (now resolved) and one for minimum bid price (still outstanding).
Item 3.01 view on EDGAR →
1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (FNGR 10-Q) is open in full — no account needed.
Partner
Trade JAGX commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 1, 2026 · How we verify